Does CAR T-cell therapy use your own cells?
Yes. Every CAR T-cell therapy approved in the United States is made from your own T cells, not from a donor's.
You can see it in the drug names. Most end in the word "autoleucel," and "auto" is short for autologous, which means the cells came from your own body. Carvykti is ciltacabtagene autoleucel. Breyanzi is lisocabtagene maraleucel. T cells are white blood cells that find and kill diseased cells. In this treatment, a lab takes yours, adds a gene to them, grows them by the hundreds of millions, and gives the same cells back to you.
The trip your cells take
The first step is apheresis, a blood-filtering procedure. Blood leaves through one line, runs through a machine that keeps the white cells, and the rest returns to you through a second line. There is no surgery. You keep your own bone marrow the whole time.
Your cells then travel to a factory. A disabled virus carries a new gene into them. That gene tells each T cell to build a chimeric antigen receptor, or CAR, which is a protein that sits on the cell surface and grabs a target found on cancer cells. The National Cancer Institute says growing the cells takes 2 to 8 weeks. Its research page puts the full loop, from blood draw to infusion, at about 3 to 5 weeks.
Just before the infusion you get a short course of chemotherapy called lymphodepletion. It lowers your other immune cells so the new ones have room to multiply. The infusion is usually a single bag and takes less than an hour.
Your own cells can still cause trouble
Because the cells are yours, your body will not reject them the way it might reject a donated kidney. CAR T-cell therapy also does not cause graft-versus-host disease, which is the attack on your tissues that donor cells can trigger after a stem cell transplant.
That is not the same as being safe. Your own engineered cells can set off cytokine release syndrome. Cytokines are immune signals, and a sudden flood of them can cause fever, nausea, headache, rash, a racing heart, low blood pressure, and trouble breathing. Most cases are mild. Some are severe or life threatening. CAR T cells can also attack healthy cells that carry the same target, which can damage organs.
Get checked now if you run a fever in the weeks after infusion, even if you feel fine otherwise. The two federal thresholds differ slightly: the CDC says call your doctor at 100.4 °F (38 °C) or higher, while NCI's infection page uses 100.5 °F. The CDC number is the one most treatment centers now hand out. Do not take acetaminophen first, because it can hide the fever your team needs to see. Confusion, tremor, or trouble finding words also needs a same-day call.
Which cancers, and what is coming
The approved products treat blood cancers. Yescarta, for example, is approved for large B-cell lymphoma, and Carvykti for multiple myeloma after earlier drugs stop working. Use in solid tumors such as breast and brain cancer is still experimental.
The one real exception is not yet on the market. Large trials are testing allogeneic CAR T cells, made from healthy donors and stocked in advance like any other drug. If those succeed, waiting weeks for your own batch may stop being the rule. Today it still is.
Sources
https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/t-cell-transfer-therapy
https://www.cancer.gov/about-cancer/treatment/research/car-t-cells
https://www.cancer.gov/about-cancer/treatment/side-effects/infection
https://www.cdc.gov/cancer-preventing-infections/patients/fever.html
Want the full picture? Read our complete explanation: What to Expect With CAR T-Cell Therapy
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.